People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Calosyn Pharma, Inc. | — | Biotechnology | Seed | $2.9M | $8.5M | 2009 |
David Waddell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Waddell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mike Sherman | 1 | 6 |
| Ross Barrett | 1 | 5 |
| Stephen Snowdy | 1 | 4 |
| Joseph Lovett | 1 | 4 |
| Joseph F. Lovett | 1 | 4 |
| Ross P. Barrett | 1 | 4 |
| William R. Grimes | 1 | 3 |
| Ross F. Barrett | 1 | 2 |
| Joseph P. Lovett | 1 | 2 |
| Stephen F. Snowdy | 1 | 1 |
| Martin Becker | 1 | 1 |
| Richard R. Babb | 1 | 1 |
| David P. Waddell | 1 | 1 |
| David F. Waddell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.